Nasdaq· Real Estate Investment Trusts· Inc. MD· CIK 0001492298

SBRA

Sabra Health Care REIT, Inc.

$19.16 ▼ -0.21%

Prev close $19.20

Market cap$5.0B

ConsensusHold

12-mo target$22.79 (+18.9%)

▲ Neutral

Analyst conviction 5/10

High Impact Filing (7/10)32 New Institutional Positions18 Institutional Exits Real Estate

Snapshot

The big-picture read on SBRA right now — valuation, ownership and activity at a glance.

Market Cap

$5.0B

Cap Size

Mid Cap

Analyst Consensus

Buy (50%)

Inst. Holders

50 funds

Inst. Value

$4.1B

Inst. Activity

32 buys / 18 sells

Insider Activity

$0.00 buy / $4.5M sell

Insider Net $

-$4.5M

SEC Reports

Price chart 30d -8.5%

Daily candles (open–high–low–close) with volume. Green = up day, red = down day.

Vol

Recent activity

The latest filings, insider trades, analyst actions, press and options flow — newest first.

Oct 1, 2026 short_volume

Short Volume: SBRA — 58.1% short (0.4M / 0.7M)

Short: 392,927 | Exempt: 7,063 | TRF Vol: 676,430 | Short Ratio: 58.1% | Off-exchange volume (dark p

Sep 8, 2026 Insider

MATROS RICHARD K sold 200,000 shares

Chair, CEO and President @ $20.83 ($4.2M)

Aug 31, 2026 Insider

Kono Ann was granted 791 shares

Director

Aug 31, 2026 Insider

KATZMANN LYNNE S was granted 791 shares

Director

Jul 21, 2026 SEC

Sabra Health Care REIT raised full-year 2026 guidance, reflecting a 7% increase in Normalized FFO and 8% in Normalized A

8-K — Impact 7/10

Jun 30, 2026 Inst.

CENTERSQUARE INVESTMENT MANAGEMENT LLC — ADD

5,814,427 shares ($113.4M)

Jun 30, 2026 Inst.

Nuveen, LLC — TRIM

4,464,764 shares ($87.1M)

Apr 24, 2026 SEC

Sabra Health Care REIT is holding its annual shareholder meeting to vote on the re-election of seven directors, ratifica

DEFA14A — Impact 3/10

Analyst ratings buy % -3.8%

How Wall Street rates the stock today, and the latest firm-by-firm actions.

Hold 50% rate it Buy or better · 22 analysts

Strong Buy 4 18% Buy 7 32% Hold 11 50% Sell 0 0% Strong Sell 0 0%

Recent analyst actions

Date	Firm	Action	Rating	Firm rating
Aug 31, 2026	Barclays	MAINTAIN	Equal-Weight	54%
Aug 31, 2026	Baird	MAINTAIN	Neutral	54%
Aug 6, 2026	Raymond James	UPGRADE	Market Perform	54%
Jul 22, 2026	Baird	MAINTAIN	Neutral	54%
Jul 22, 2026	Truist Securities	MAINTAIN	Buy	55%
Jul 22, 2026	Citizens	MAINTAIN	Market Outperform	38%
Jul 8, 2026	UBS	MAINTAIN	Neutral	55%
Jul 8, 2026	Truist Securities	UPGRADE	Buy	55%
Jul 7, 2026	Barclays	INITIATE	Equal-Weight	54%
Jun 23, 2026	Citigroup	DOWNGRADE	Neutral	55%

Monthly consensus history

Period	Str. Buy	Buy	Hold	Sell	Buy %
Sep 1, 2026	4	7	11	0	50%
Aug 1, 2026	4	7	10	1	50%
Jul 1, 2026	4	6	10	1	48%
Jun 1, 2026	5	6	9	0	55%
May 1, 2026	5	6	9	0	55%
Apr 1, 2026	5	6	9	0	55%
Mar 1, 2026	5	6	9	0	55%
Feb 1, 2026	5	6	9	0	55%

Price targets

Where 14 covering analysts think SBRA trades over the next 12 months.

$22.79 +18.9% upside Buy

Current$19.16 Low$19.00 Median$23.00 High$25.00 14 analysts

$19.00$25.00

Analyst rating Buy· 2.3/5 as of Oct 2, 2026

Reports & filings

AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.

2 SEC filing reports analyzed · 1 bullish, 0 bearish, 0 mixed, 1 neutral · avg impact 5.0/10.

BULLISH8-K7/10

Sabra Health Care REIT raised full-year 2026 guidance, reflecting a 7% increase in Normalized FFO an

Jul 21, 2026

NEUTRALDEFA14A3/10

Sabra Health Care REIT is holding its annual shareholder meeting to vote on the re-election of seven

Apr 24, 2026

Upcoming & catalyst events

Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.

Oct 1, 2026

short_volume

Short Volume: SBRA — 58.1% short (0.4M / 0.7M)

Short: 392,927 | Exempt: 7,063 | TRF Vol: 676,430 | Short Ratio: 58.1% | Off-exchange volume (dark pool + OTC)

Sep 30, 2026

short_volume

Short Volume: SBRA — 56.3% short (0.3M / 0.6M)

Short: 333,160 | Exempt: 97 | TRF Vol: 591,902 | Short Ratio: 56.3% | Off-exchange volume (dark pool + OTC)

Sep 24, 2026

short_volume

Short Volume: SBRA — 58.7% short (0.4M / 0.7M)

Short: 427,984 | Exempt: 0 | TRF Vol: 728,736 | Short Ratio: 58.7% | Off-exchange volume (dark pool + OTC)

Sep 23, 2026

short_volume

Short Volume: SBRA — 61.7% short (0.5M / 0.9M)

Short: 546,310 | Exempt: 185 | TRF Vol: 885,051 | Short Ratio: 61.7% | Off-exchange volume (dark pool + OTC)

Sep 22, 2026

short_volume

Short Volume: SBRA — 61.8% short (0.5M / 0.8M)

Short: 471,258 | Exempt: 0 | TRF Vol: 762,925 | Short Ratio: 61.8% | Off-exchange volume (dark pool + OTC)

Earnings estimates

Forecast earnings per share and revenue by period — and whether estimates are rising.

Period	EPS Est.	Range	Growth	30d Rev	Up/Dn	Revenue	#
Current Q	$0.17	$0.16–$0.17	-0.8%	-1.0%	0↑ 1↓	$0.2B	2
Next Q	$0.17	$0.17–$0.18	9.9%	-0.9%	—	$0.2B	2
Current FY	$0.48	$0.39–$0.75	-24.3%	-29.5%	0↑ 3↓	$0.9B	8
Next FY	$0.81	$0.77–$0.85	—	+6.6%	1↑ 0↓	$1.0B	2

Current-quarter EPS estimate — revision history

When	EPS estimate	Change vs now
Current	$0.165	—
7d ago	$0.167	-0.002
30d ago	$0.167	-0.002
60d ago	$0.170	-0.005
90d ago	$0.170	-0.005

Institutional ownership

Which big funds own SBRA (from quarterly 13F filings) and who is adding or trimming.

50 institutional holders with $4.1B total value (211,274,417 shares) as of 2026-Q2. Top holders: BlackRock,, PRINCIPAL, VANGUARD. Net buying activity: 32 institutions added/increased vs 18 reduced.

Top holders — 2026-Q2

Fund	Shares	Value	% Tracked	Last move
BlackRock, Inc.	41,614,351	$811.9M	19.7%	—
PRINCIPAL FINANCIAL GROUP INC	24,706,070	$482.0M	11.7%	—
VANGUARD PORTFOLIO MANAGEMENT LLC	23,352,373	$455.6M	11.1%	—
STATE STREET CORP	12,305,655	$240.1M	5.8%	—
VANGUARD CAPITAL MANAGEMENT LLC	11,349,125	$221.4M	5.4%	—
GEODE CAPITAL MANAGEMENT, LLC	7,909,172	$154.3M	3.7%	—
CENTERSQUARE INVESTMENT MANAGEMENT LLC	5,814,427	$113.4M	2.8%	ADD +49.9%
BANK OF AMERICA CORP /DE/	5,300,762	$103.4M	2.5%	—
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	4,840,401	$94.4M	2.3%	—
Nuveen, LLC	4,464,764	$87.1M	2.1%	TRIM -33.1%

Recent position changes

Fund	Action	Prev	Current	Change	Value
CENTERSQUARE INVESTMENT MANAGEMENT LLC	ADD	3,877,810	5,814,427	+49.9%	$113.4M
Nuveen, LLC	TRIM	6,673,284	4,464,764	-33.1%	$87.1M
NORGES BANK	NEW	—	3,313,984	—	$64.7M
JPMORGAN CHASE & CO	TRIM	8,201,220	3,231,743	-60.6%	$63.3M
Qube Research & Technologies Ltd	DOUBLED	73,006	1,472,529	+1917.0%	$28.7M
CITIGROUP INC	DOUBLED	325,744	1,267,385	+289.1%	$24.7M
MACKENZIE FINANCIAL CORP	ADD	628,780	1,170,196	+86.1%	$22.8M
Point72 Asset Management, L.P.	ADD	560,245	1,115,011	+99.0%	$21.8M
Russell Investments Group, Ltd.	ADD	658,822	1,091,203	+65.6%	$21.3M
MILLENNIUM MANAGEMENT LLC	TRIM	1,584,982	746,172	-52.9%	$14.6M

Insider activity

Buying and selling by company executives and directors (SEC Form 4).

10 insiders, 49 transactions. Net -$4.5M — $0.00 bought, $4.5M sold.

Date	Insider	Title	Type	Shares	Price	Value
Sep 8, 2026	MATROS RICHARD K	Chair, CEO and President	SELL	200,000	$20.83	$4.2M
Aug 31, 2026	Kono Ann	Director	AWARD	791	—	—
Aug 31, 2026	KATZMANN LYNNE S	Director	AWARD	791	—	—
Aug 31, 2026	Costa Michael Lourenco	Executive VP, CFO & Treasurer	AWARD	4,158	—	—
Aug 31, 2026	Cusack Catherine	Director	AWARD	791	—	—
Aug 31, 2026	Barbarosh Craig A.	Director	AWARD	791	—	—
Aug 31, 2026	Malehorn Jeffrey A.	Director	AWARD	791	—	—
Aug 31, 2026	FLORES JESSICA	Executive VP & CAO	AWARD	382	—	—
Aug 31, 2026	FOSTER MICHAEL J	Director	AWARD	791	—	—
Aug 31, 2026	Smith Darrin	Executive VP, CIO & Secretary	AWARD	495	—	—

Short interest & halts

FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for SBRA.

Shares short

21,015,330

Settlement Sep 15, 2026

Change vs prior

+8.4%

Semi-monthly cycle

Days to cover

9.1

At avg daily volume

Of shares outstanding

≈8.2%

Estimate — not % of float

All SBRA filing & press-release reports (2)

8-K reportJul 21, 2026
DEFA14A reportApr 24, 2026